Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
182 hedge funds and large institutions have $2.67B invested in Inari Medical, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 75 increasing their positions, 57 reducing their positions, and 42 closing their positions.
55% more call options, than puts
Call options by funds: $14.5M | Put options by funds: $9.36M
32% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 57
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $2.7B → $2.67B (-$34.1M)
10% less funds holding
Funds holding: 202 → 182 (-20)
40% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$165M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$93M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$48.3M |
| 4 |
BlackRock
New York
|
+$35.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$80.4M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$77.2M |
| 3 |
PA
Perceptive Advisors
New York
|
-$29M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$17.1M |
| 5 |
Millennium Management
New York
|
-$13.8M |
NARI Hedge Fund Activity: Q3 2021 in Review
182 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q3 2021, worth a combined $2.67B — down 1.3% from $2.7B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of NARI and 25 opened new positions — a net loss of 17 holders — while 57 trimmed existing stakes and 75 added.
The largest buyer was Capital International Investors, adding an estimated $165M. The largest seller was Citadel Advisors, cutting an estimated $80.4M.
- 182 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q3 2021, down from 202 in Q2 2021.
- Funds reported $2.67B of Inari Medical, Inc. Common Stock stock for Q3 2021, down 1.3% quarter-over-quarter.
- 25 funds opened new Inari Medical, Inc. Common Stock positions in Q3 2021 and 42 closed out, a net change of -17 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q3 2021 was Capital International Investors, an estimated $165M added.
- The largest Inari Medical, Inc. Common Stock seller in Q3 2021 was Citadel Advisors, an estimated $80.4M sold.
Based on aggregated 13F filings for Q3 2021.